"Patient age at first cataract surgery and the age-standardized surgery rate vary considerably among some US communities, according to results of a study published online December 30 in JAMA Ophthalmology.
The rate of cataract"...
(phenylephrine and ketorolac) Injection
Omidria is a sterile aqueous solution concentrate containing the α1-adrenergic receptor agonist phenylephrine HCl and the nonsteroidal anti-inflammatory ketorolac tromethamine.
The descriptions and structural formulae are
Phenylephrine Hydrochloride Drug Substance
Common Name: phenylephrine hydrochloride
Chemical Name: (-)-m-Hydroxy-α-[(methylamino)methyl]benzyl alcohol hydrochloride
Molecular Formula: C9H13NO2 • HCl Molecular Weight: 203.67 g/mole
Figure 1: Chemical Structure for Phenylephrine HCl
Ketorolac Tromethamine Drug Substance
Common Name: ketorolac tromethamine
Chemical Name: (±)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Molecular Formula: C15H13NO3 •C4H11NO3 Molecular Weight: 376.40 g/mole
Figure 2: Chemical Structure for Ketorolac Tromethamine
Omidria is a clear, colorless to slightly yellow, sterile solution concentrate with a pH of approximately 6.3.
Each vial of Omidria contains
Actives: phenylephrine hydrochloride 12.4 mg/mL equivalent to 10.16 mg/mL of phenylephrine and ketorolac tromethamine 4.24 mg/mL equivalent to 2.88 mg/mL of ketorolac.
Inactives: citric acid monohydrate; sodium citrate dihydrate; water for injection; may include sodium hydroxide and/or hydrochloric acid for pH adjustment.
Last reviewed on RxList: 1/28/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional Omidria Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.